Methodologic problems in the assessment of bleed scores

Journal of the American College of Cardiology

Volumn 61, Issue 4, 2013, Pages 481-

  Singer, Daniel E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; IDRAPARINUX;

ANTICOAGULATION; ATRIA SCORE; BLEEDING; BRAIN HEMORRHAGE; HAS-BLED SCORE; HEART ATRIUM FIBRILLATION; HEMORRHAGE SCORE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; METHODOLOGY; PRIORITY JOURNAL; SCORING SYSTEM;

ANTICOAGULANTS; FEMALE; HEMORRHAGE; HUMANS; MALE; WARFARIN;

EID: 84872743492     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.052     Document Type: Letter

References (5)

1. S. Apostolakis, D.A. Lane, Y. Guo, H. Buller, G.Y. Lip Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study J Am Coll Cardiol 60 2012 861 867
2. R. Pisters, D.A. Lane, R. Nieuwlaat A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey Chest 138 2010 1093 1100
3. B.F. Gage, Y. Yan, P.E. Milligan Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF) Am Heart J 151 2006 713 719
4. M.C. Fang, A.S. Go, Y. Chang A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study J Am Coll Cardiol 58 2011 395 401
5. M.G. Bousser, J. Bouthier, H.R. Büller AMADEUS Investigators Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial Lancet 371 2008 315 321